Role of the ABCE1 gene in human lung adenocarcinoma
- Authors:
- Yi Ren
- Yinghui Li
- Dali Tian
View Affiliations
Affiliations: Department of Thoracic Surgery, the Fourth Affiliated Hospital of China Medical University, Shenyan 110032, P.R. China, Department of Medical Genetics, College of Basic Medical Sciences, China Medical University, Shenyang 110001, P.R. China
- Published online on: January 19, 2012 https://doi.org/10.3892/or.2012.1646
-
Pages:
965-970
Metrics: Total
Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
Abstract
ATP-binding cassette transporter E1 (ABCE1), also known as RLI (RNase L inhibitor), is a new type of endoribonuclease inhibitor, which can specifically bind to RNase L and abolish its effect. ABCE1 binds to eIF2α and eIF5 to form a pre-translation initiation complex, suggesting its crucial role in cell growth, development and certain pathological processes. To probe the role of ABCE1 in the development and progress of human lung adenocarcinoma, we first detected the changes of its mRNA and protein expression in tissues, and found a high expression level of ABCE1 in human lung adenocarcinoma tissues and metastatic lymph nodes, which was also correlated with clinical stages. Moreover, human lung adenocarcinoma A549 cells were infected with lentiviral vectors containing ABCE1-specific shRNA, and resulted in significant inhibition of cell growth. Using microarray assay, a number of differentially expressed genes were found after ABCE1 suppression. Our results demonstrated the potential role of ABCE1 in human lung adenocarcinoma, which may provide some molecular basis for the mechanisms of development and progress of human lung adenocarcinoma, and help to find new pharmacological targets.
View References
1
|
Bisbal C, Silhol M, Laubenthal H, et al:
The 2′-5′ oligoadenylate/RNase L/RNase L inhibitor pathway
regulates both MyoD mRNA stability and muscle cell differentiation.
Mol Cell Biol. 20:4959–4969. 2000.
|
2
|
Hassel BA, Zhou A, Sotomayor C, Maran A
and Silverman RH: A dominant negative mutant of 2–5A-dependent
RNase suppresses antiproliferative and antiviral effects of
interferon. EMBO J. 12:3297–3304. 1993.
|
3
|
Le Roy F, Bisbal C, Silhol M, Martinand C,
Lebleu B and Salehzada T: The 2–5A/RNase L/RNase L inhibitor (RLI)
[correction of (RNI)] pathway regulates mitochondrial mRNAs
stability in interferon alpha-treated H9 cells. J Biol Chem.
276:48473–48482. 2001.
|
4
|
Salzberg S, Lanciano F and Hacohen D:
Reversibility of the antiproliferative effect of interferon. Nat
Immun Cell Growth Regul. 9:191–202. 1990.PubMed/NCBI
|
5
|
Chen ZQ, Dong J, Ishimura A, et al: The
essential vertebrate ABCE1 protein interacts with eukaryotic
initiation factors. J Biol Chem. 281:7452–7457. 2006. View Article : Google Scholar : PubMed/NCBI
|
6
|
Karcher A, Buttner K, Martens B, et al:
X-ray structure of RLI, an essential twin cassette ABC ATPase
involved in ribosome biogenesis and HIV capsid assembly. Structure.
13:649–659. 2005. View Article : Google Scholar : PubMed/NCBI
|
7
|
Chen ZQ, Dong J, Ishimura A, Daar I,
Hinnebusch AG and Dean M: The essential vertebrate ABCE1 protein
interacts with eukaryotic initiation factors. J Biol Chem.
28:7452–7457. 2006. View Article : Google Scholar : PubMed/NCBI
|
8
|
Fornace AJ Jr, Alamo I Jr and Hollander
MC: DNA damage-inducible transcripts in mammalian cells. Proc Natl
Acad Sci USA. 85:8800–8804. 1988. View Article : Google Scholar : PubMed/NCBI
|
9
|
Kastan MB, Zhan Q, el-Deiry WS, et al: A
mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is
defective in ataxia-telangiectasia. Cell. 71:587–597. 1992.
View Article : Google Scholar : PubMed/NCBI
|
10
|
Gujuluva CN, Baek JH, Shin KH, et al:
Effect of UV-irradiation on cell cycle, viability and the
expression of p53, gadd153 and gadd45 genes in normal and
HPV-irnmortalized human oral keratinocytes. Oncogene. 9:1819–1827.
1994.PubMed/NCBI
|
11
|
Kearsey JM, Coates PJ, Prescott AR,
Warbrick E and Hall PA: Gadd45 is a nuclear cell cycle regulated
protein which interacts with p21Cip1. Oncogene. 11:1675–1683.
1995.PubMed/NCBI
|
12
|
Yamasawa K, Nio Y, Dong M, Yamaguchi K and
Itakura M: Clinicopathological significance of abnormalities in
Gadd45 expression and its relationship to p53 in human pancreatic
cancer. Clin Cancer Res. 8:2563–2569. 2002.PubMed/NCBI
|
13
|
Tront JS, Hoffman B and Liebermann DA:
Gadd45a suppresses Ras-driven mammary tumorigenesis by activation
of c-Jun NH2-terminal kinase and p38 stress signaling resulting in
apoptosis and senescence. Cancer Res. 66:8448–8454. 2006.
View Article : Google Scholar : PubMed/NCBI
|